rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Patrick V.J.J. Vink

Director

Company insider

Files Form 4 as: Director, Spero Therapeutics; Director, SQZ Biotechnologies Co; EVP and COO, Cubist Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
44
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
2
First trade
15 Oct 2012
Last trade
23 Jun 2026
Last filed
25 Jun 2026

Companies traded

Where they are an officer
Cubist PharmaceuticalsOfficer · last 21 Jan 20150 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
SPRO Spero TherapeuticsDirector · Biotechnology · last 23 Jun 20260 buys · 0 sells
SQZ Biotechnologies CoDirector · last 14 Jun 20230 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
23 Jun 2026filed 25 Jun 2026SPRO Spero TherapeuticsBiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
23 Jun 2026filed 25 Jun 2026SPRO Spero Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
23 Jun 2026filed 25 Jun 2026SPRO Spero Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
23 Jun 2026filed 25 Jun 2026SPRO Spero TherapeuticsBiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
12 Jun 2025filed 16 Jun 2025SPRO Spero TherapeuticsBiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
29 May 2024filed 30 May 2024SPRO Spero TherapeuticsBiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
5 Oct 2023filed 10 Oct 2023SPRO Spero TherapeuticsBiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
14 Jun 2023filed 15 Jun 2023SQZ Biotechnologies Cooption or derivativeSEC FORM 4 Code A—39,875 at $0.00filing
3 Jan 2023filed 5 Jan 2023SPRO Spero Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A$20K15,471 at $1.29filing
15 Sep 2022filed 19 Sep 2022SPRO Spero TherapeuticsBiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
15 Jun 2022filed 16 Jun 2022SQZ Biotechnologies Cooption or derivativeSEC FORM 4 Code A—20,000 at $0.00filing
5 Jan 2022filed 7 Jan 2022SPRO Spero Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A$20K2,214 at $9.03filing
17 Aug 2021filed 18 Aug 2021SPRO Spero Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
1 Jul 2021filed 1 Jul 2021SQZ Biotechnologies Cooption or derivativeSEC FORM 4 Code A—21,000 at $0.00filing
4 Jan 2021filed 6 Jan 2021SPRO Spero Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A$17K1,314 at $13.31filing
27 Oct 2020filed 27 Oct 2020SPRO Spero Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
2 Jan 2020filed 6 Jan 2020SPRO Spero Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A$35K5,408 at $6.47filing
5 Jun 2019filed 5 Jun 2019SPRO Spero Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—6,073 at $0.00filing
5 Jun 2018filed 6 Jun 2018SPRO Spero Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—6,073 at $0.00filing
21 Jan 2015filed 21 Jan 2015Cubist PharmaceuticalsSEC FORM 4 Code J$561K5,496 at $102.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.